Table 2 |
||
|
Characteristics of diabetic patients in MHCs and non-MHCs at the start of follow up (T0) |
||
|
Patient characteristic* |
MHCs (n = 17,045) |
Non MHCs (n = 26,626) |
|
|
||
|
Age, years, % |
||
|
< 45 |
20.7% |
11.5% |
|
45 to 54 |
19.7% |
14.3% |
|
55 to 64 |
21.6% |
20.7% |
|
65 to 74 |
18.6% |
23.2% |
|
≥75 |
19.3% |
30.3% |
|
Sex, % male |
41.9% |
43.8% |
|
Indigenous status, % |
||
|
Indigenous |
11.8% |
5.6% |
|
Non-Indigenous |
88.1% |
91.1% |
|
Missing |
0.1% |
3.3% |
|
Level of social disadvantage |
||
|
Most disadvantaged |
15.1% |
10.5% |
|
More disadvantaged |
22.7% |
21.1% |
|
Little disadvantaged |
24.5% |
23.8% |
|
Less disadvantaged |
17.3% |
17.8% |
|
Least disadvantaged |
19.0% |
25.8% |
|
Missing |
1.3% |
1.0% |
|
Residential remoteness |
||
|
Metropolitan |
64.8% |
70.9% |
|
Rural |
25.0% |
22.7% |
|
Remote |
9.8% |
6.3% |
|
Missing |
0.4% |
0.1% |
|
Charlson comorbidity score, mean (SD) |
0.83 (1.62) |
0.63 (1.43) |
|
Diabetes recorded before T0, % |
34.8% |
31.6% |
|
Type of treatment at one year, % |
||
|
No diabetic medications |
53.1% |
52.5% |
|
Oral hypoglycemic agents only |
39.0% |
40.9% |
|
Insulin |
7.9% |
6.6% |
|
Type of treatment at up to 16 years, % |
||
|
No diabetic medications |
33.6% |
32.6% |
|
Oral hypoglycemic agents only |
47.7% |
51.0% |
|
Insulin |
18.7% |
16.4% |
|
Type of mental disorders |
||
|
- Alcohol/drug disorders |
8.7% |
|
|
- Schizophrenia |
4.8% |
|
|
- Affective psychoses |
18.6% |
|
|
- Other psychoses |
10.7% |
|
|
- Neurotic disorders |
17.6% |
|
|
- Personality disorders |
2.2% |
|
|
- Adjustment reaction |
5.1% |
|
|
- Depressive disorder |
4.9% |
|
|
- Other mental disorders |
5.9% |
|
|
- Other than mental or behavioural disorders |
21.6% |
|
|
|
||
|
Abbreviations: MHCs, mental health clients, SD, standard deviation. *P < 0.001 for all comparisons. |
||
|
Mai et al. BMC Medicine 2011 9:118 doi:10.1186/1741-7015-9-118 |
||
